Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

The aim of our study was to determine the potential role of CT-based radiomics in predicting treatment response and survival in patients with advanced NSCLC treated with immune checkpoint inhibitors. We retrospectively included 188 patients with NSCLC treated with PD-1/PD-L1 inhibitors from two inde...

Full description

Bibliographic Details
Main Authors: François Cousin, Thomas Louis, Sophie Dheur, Frank Aboubakar, Benoit Ghaye, Mariaelena Occhipinti, Wim Vos, Fabio Bottari, Astrid Paulus, Anne Sibille, Frédérique Vaillant, Bernard Duysinx, Julien Guiot, Roland Hustinx
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
NSCLC
immune checkpoint inhibitors
radiomics
delta-radiomics
computed tomography
Online Access:https://www.mdpi.com/2072-6694/15/7/1968

Internet

https://www.mdpi.com/2072-6694/15/7/1968

Similar Items